FDA Inspection 1095974 — Astellas Pharma Inc.
The FDA completed an inspection of Astellas Pharma Inc. on May 31, 2019 in Toyama. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 31, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Toyama (Japan)